Recently, FGFR1-TACC1 and FGFR3-TACC3 fusions have been identified in approximately 3% of glioblastoma multiforme tumor samples [16] and FGFR3-TACC3 fusions were identified in a subset of bladder carcinomas [17]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.